Skip to content

Pharmadons

Active
Private limited companyfounded 200619 yrs activeFrançois Donsstraat 32, 1050 Elsene, BelgiumKBO/BCE: BE 0885.520.423
Summary

Pharmadons has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €98,180 and a net result of -€9,746. Equity is growing by ~24.3% per year across the filed fiscal years. Its solvency ranks better than 26% of 10429 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.3% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability17=
Solvency41▼-59
Growth52=
Track record100
Bankruptcy probability, 12 months
1.3% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3,000 at 30 days only on tighter terms
Liquidity tight (current ratio 1.19 against 4.39 in 2024; short-term debt: 81.7% and cash: 8.2% of total assets), and 83.9% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 19 years 0 20 y
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
16.1%
Return on assets
-1.6%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-08-2026, 14 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
14 d late
2024
11 d late
2023
36 d early
2022
28 d late
2021
38 d early
2020
26 d early
2019
25 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 10 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Pharmadons was incorporated on 8 December 2006.1 Total assets rose from EUR 200,868 in 2018 to EUR 608,875 in 2025 and headcount from 2.8 to 1.3 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€9,746▼ 35.5%
2024 · -€7,195
Working capital
€96,664▼ 76.4%
2024 · €408,794
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€96,063▼ 13.0%€88,239▼ 8.1%€78,988▼ 10.5%-€3,359-€10,809▼ 222%
Net result€74,964▼ 12.3%€69,316▼ 7.5%€56,867▼ 18.0%-€7,195-€9,746▼ 35.5%
Equity€276,538▲ 37.2%€345,854▲ 25.1%€415,121▲ 20.0%€407,926▼ 1.7%€98,180▼ 75.9%
Total assets€334,988▲ 20.8%€424,624▲ 26.8%€469,098▲ 10.5%€534,160▲ 13.9%€608,875▲ 14.0%
Debt€58,449▼ 22.9%€78,770▲ 34.8%€53,977▼ 31.5%€126,234▲ 134%€510,695▲ 305%
Working capital€272,089▲ 39.4%€337,535▲ 24.1%€409,549▲ 21.3%€408,794▼ 0.2%€96,664▼ 76.4%
Staff (FTE)2=2=2.3▲ 15.0%2▼ 13.0%1.3▼ 35.0%
Why a figure moved sharply
  • 2025 Equity -76% on 2024. Cause not known from the registers.
Result per fiscal year
Operating resultNet result
-€50,000€0€50,000€100,000Operating result 2021: €96,063€96,063Net result 2021: €74,964€74,964Operating result 2022: €88,239€88,239Net result 2022: €69,316€69,316Operating result 2023: €78,988€78,988Net result 2023: €56,867€56,867Operating result 2024: -€3,359-€3,359Net result 2024: -€7,195-€7,195Operating result 2025: -€10,809-€10,809Net result 2025: -€9,746-€9,74620212022202320242025-€25,000€0€25,000€50,000€75,000Operating result 2023: €78,988€79,000Net result 2023: €56,867€56,900Operating result 2024: -€3,359-€3,360Net result 2024: -€7,195-€7,200Operating result 2025: -€10,809-€10,800Net result 2025: -€9,746-€9,750202320242025
The operating result stays negative: a loss of €10,809 in 2025 against €3,359 in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €608,875
Fixed assets €14,621 ▲ 195%
Current assets €594,254 ▲ 12.3%
Equity and liabilities €608,875
Equity €98,180 ▼ 75.9%
Debt €510,695 ▲ 305%
Debt's share of the balance-sheet total rises from 23.6% to 83.9%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
-€8,741▼
2024 · -€1,503
Cash flow
-€7,678▼
2024 · -€5,339
Current ratio
1.19▼
2024 · 4.39
Quick ratio
1.03▼
2024 · 3.55
Debt to equity
5.20▲
2024 · 0.31
ROE
-9.9%▼
2024 · -1.8%
ROA
-1.6%▼
2024 · -1.3%
Interest coverage
-1.97▼
2024 · -0.39
Debt ≤ 1 year
€497,590▲
2024 · €120,412
Debt > 1 year
€13,105▲
2024 · €5,822
Income taxes
-€5,434▼
2024 · €0
Staff costs
€118,426▼
2024 · €150,691
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,164 companies that looked in July 2024 the way this one looks now, 2.2% went bankrupt within 24 months and 94% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a small loss
2.2% went bankrupt
3.0% stopped otherwise
94% still going

A further 0.9% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 1.3% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,164 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 54 lines
Balance sheet Code20242025
Assets
Total assets20/58€534,160€608,875▲
Fixed assets21/28€4,955€14,621▲
Tangible fixed assets22/27€4,955€10,121▲
Plant, machinery and equipment23€0€4,937▲
Furniture and vehicles24€4,955€5,184▲
Financial fixed assets28-€4,500
Current assets29/58€529,205€594,254▲
Stocks and contracts in progress3€101,210€81,593▼
Stocks30/36€101,210€81,593▼
Amounts receivable within one year40/41€365,228€455,489▲
Trade receivables40€45,795€50,825▲
Other amounts receivable41€319,433€404,664▲
Cash at bank and in hand54/58€61,130€49,883▼
Deferred charges and accrued income490/1€1,638€7,289▲
Equity and liabilities
Total equity and liabilities10/49€534,160€608,875▲
Equity10/15€407,926€98,180▼
Contributions10/11€18,600€18,600=
Reserves13€1,860€1,860=
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€1,860€1,860=
Profit (loss) carried forward14€387,466€77,720▼
Amounts payable17/49€126,234€510,695▲
Amounts payable after more than one year17€5,822€13,105▲
Financial debts170/4€5,822€0▼
Other amounts payable178/9-€13,105
Amounts payable within one year42/48€120,412€497,590▲
Current portion of amounts payable after more than one year42€14,178€18,329▲
Financial debts43€0€28,379▲
Credit institutions430/8€0€28,379▲
Trade debts44€85,139€135,996▲
Suppliers440/4€85,139€135,996▲
Taxes, remuneration and social security45€17,441€14,886▼
Taxes450/3€6,930€0▼
Remuneration and social security454/9€10,511€14,886▲
Other amounts payable47/48€3,654€300,000▲
Income statement Code20242025
Remuneration, social security and pensions62€150,691€118,426▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,856€2,068▲
Other operating charges640/8€392€416▲
Gross operating margin9900€149,579€110,101▼
Operating profit (loss)9901-€3,359-€10,809▼
Financial income75/76B€3€67▲
Recurring financial income75€3€67▲
Financial charges65/66B€3,839€4,439▲
Recurring financial charges65€3,839€4,439▲
Profit (loss) for the period before taxes9903-€7,195-€15,180▼
Income taxes67/77€0-€5,434▼
Profit (loss) for the period9904-€7,195-€9,746▼
Profit (loss) for the period to be appropriated9905-€7,195-€9,746▼
Appropriation of the result
Profit (loss) to be appropriated9906€387,466€377,720▼
Profit (loss) brought forward from the previous period14P€394,661€387,466▼
Profit to be distributed694/7-€300,000
Return on contributions (dividend)694-€300,000
Social balance
Average headcount (FTE)90872.01.3▼

The notes to these accounts (18 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62€113,222€123,488€125,399€150,691€118,426▼ 21.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,990€2,130€2,746€1,856€2,068▲ 11.4%
Other operating charges640/8€1€0-€392€416▲ 6.3%
Gross operating margin9900€211,276€213,857€207,133€149,579€110,101▼ 26.4%
Operating profit (loss)9901€96,063€88,239€78,988-€3,359-€10,809▼ 222%
Financial income75/76B€1--€3€67▲ 2,505%
Recurring financial income75€1--€3€67▲ 2,505%
Financial charges65/66B€2,101€1,633€2,192€3,839€4,439▲ 15.6%
Recurring financial charges65€2,101€1,633€2,192€3,839€4,439▲ 15.6%
Profit (loss) for the period before taxes9903€93,962€86,605€76,797-€7,195-€15,180▼ 111%
Income taxes67/77€18,998€17,289€19,930€0-€5,434-
Profit (loss) for the period9904€74,964€69,316€56,867-€7,195-€9,746▼ 35.5%
Profit (loss) for the period to be appropriated9905€74,964€69,316€56,867-€7,195-€9,746▼ 35.5%
Line20212022202320242025Change
Assets
Total assets20/58€334,988€424,624€469,098€534,160€608,875▲ 14.0%
Fixed assets21/28€4,449€8,319€5,573€4,955€14,621▲ 195%
Tangible fixed assets22/27€4,449€8,319€5,573€4,955€10,121▲ 104%
Plant, machinery and equipment23€921€2,257€1,179€0€4,937-
Furniture and vehicles24€3,528€6,062€4,393€4,955€5,184▲ 4.6%
Financial fixed assets28----€4,500-
Current assets29/58€330,538€416,305€463,526€529,205€594,254▲ 12.3%
Stocks and contracts in progress3€95,388€98,111€99,537€101,210€81,593▼ 19.4%
Stocks30/36€95,388€98,111€99,537€101,210€81,593▼ 19.4%
Amounts receivable within one year40/41€49,561€34,982€37,851€365,228€455,489▲ 24.7%
Trade receivables40€46,061€34,982€34,833€45,795€50,825▲ 11.0%
Other amounts receivable41€3,500-€3,018€319,433€404,664▲ 26.7%
Cash at bank and in hand54/58€185,213€282,880€325,729€61,130€49,883▼ 18.4%
Deferred charges and accrued income490/1€376€331€408€1,638€7,289▲ 345%
Equity and liabilities
Total equity and liabilities10/49€334,988€424,624€469,098€534,160€608,875▲ 14.0%
Equity10/15€276,538€345,854€415,121€407,926€98,180▼ 75.9%
Contributions10/11€6,200€6,200€18,600€18,600€18,600=
Reserves13€1,860€1,860€1,860€1,860€1,860=
Non-distributable reserves130/1€1,860€1,860€1,860€0--
Reserves not available under the articles1311€1,860€1,860€1,860€0--
Distributable reserves133---€1,860€1,860=
Profit (loss) carried forward14€268,478€337,794€394,661€387,466€77,720▼ 79.9%
Amounts payable17/49€58,449€78,770€53,977€126,234€510,695▲ 305%
Amounts payable after more than one year17---€5,822€13,105▲ 125%
Financial debts170/4---€5,822€0▼ 100%
Other amounts payable178/9----€13,105-
Amounts payable within one year42/48€58,449€78,770€53,977€120,412€497,590▲ 313%
Current portion of amounts payable after more than one year42---€14,178€18,329▲ 29.3%
Financial debts43€7,926€4,264€4,099€0€28,379-
Credit institutions430/8€7,926€4,264€4,099€0€28,379-
Trade debts44€23,165€38,666€20,969€85,139€135,996▲ 59.7%
Suppliers440/4€23,165€38,666€20,969€85,139€135,996▲ 59.7%
Taxes, remuneration and social security45€23,790€28,434€28,908€17,441€14,886▼ 14.7%
Taxes450/3€9,095€12,246€11,753€6,930€0▼ 100%
Remuneration and social security454/9€14,695€16,188€17,155€10,511€14,886▲ 41.6%
Other amounts payable47/48€3,568€7,405-€3,654€300,000▲ 8,110%
Line20212022202320242025Change
Profit (loss) for the period9904€74,964€69,316€56,867-€7,195-€9,746▼ 35.5%
+ Depreciation and write-downs630€1,990€2,130€2,746€1,856€2,068▲ 11.4%
Operating cash flow (approximation)€76,954€71,447€59,613-€5,339-€7,678▼ 43.8%
Investment in fixed assets (approximation)--€6,000€0-€1,238-€11,735▼ 848%
Change in cash-€97,668€42,849-€264,599-€11,247▲ 95.7%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
14-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 14 days late
2025
31-12
Financial Weakest financial yearnet -€9,746
Net result drops to -€9,746, the lowest in the series.
11-08
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 11 days late
2024
25-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
28-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 28 days late
2022
23-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
05-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Highest result since 2018net €85,483 ▲187%
Operating result €110,390, net result €85,483, both a record.
31-12
Financial Equity above €200,000Eq €201,574 ▲73.6%
3 profitable years in a row build equity to €201,574.
06-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Equity above €100,000Eq €116,092 ▲34.6%
2 profitable years in a row build equity to €116,092.
27-06
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
27-06
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
26-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts

We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2006
seat establishment The establishment unit on the map
Ground area
108 m²
Building footprint
84 m²
Volume, LiDAR
1,974 m³
Parcel 21446D0012/00S004, Brussels · tallest building 26.1 m, ±8 floors. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Pharmadons
François Donsstraat 32, 1050 ElseneWarehousing and support activities for transportation
since 20062.158.251.582
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21446D0012/00S004 Brussels 108 m² 1 · 84 m² 26.1 m · 8 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,860. 3,409 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded08-12-2006
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0885520423
Also 9925:BE0885520423
Registered 04-12-2025

Register as of 26 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.